pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 30·1 min read
save

CVS Health explores clinical AI but cites barriers to broader use

Apr 30, 2026·read at Endpoints ↗Neutral

CVS Health's President of Health Care Delivery Sree Chaguturu discussed the company's ongoing experiments with artificial intelligence tools aimed at delivering clinical services.

The testing has shown promise, indicating AI could support various aspects of patient care, but Chaguturu highlighted several obstacles that limit wider deployment, such as integration challenges, regulatory uncertainty, and workflow compatibility.

For now, CVS plans to continue limited pilots while working to address these issues before scaling AI solutions across its network.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “CVS' healthcare delivery chief eyes potential in clinical AI”

read at Endpoints ↗
82 words · retrieved May 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 8h agoNew ICER report suggests drug launch prices are outpacing their worthEndpoints
  • 11h agoAn EHR giant backs consumer healthcareEndpoints
  • 12h agoPfizer ends Phase 2 autoimmune study; Lycia aims for $227M IPOEndpoints
  • 13h agoBiopharma Sentiment Index | Q3 2026 survey resultsEndpoints
  • 14h agoExclusive: Astellas partners with Boston ‘miniproteins’ startupEndpoints